Results 241 to 250 of about 228,341 (358)

DNAH5, A Possible Genetic Marker in Diagnosing Connective Tissue Disease-Associate Interstitial Lung Disease (CTD-ILD) [PDF]

, 2020
Jie Zhao, Yan Zhu, Qun Jin, Wenyuan Duan, Yang Li   +4 more
openalex  

Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
A considerable number of oral antitumor therapeutics (OAT) has the potential for causing pseudo‐worsening of kidney function (PW) due to inhibition of renal creatinine secretion, i.e., kidney function is unaffected, while creatinine‐based calculation of glomerular filtration rate (eGFR) erroneously indicates an impaired kidney function.
Michael I. Sponfeldner, Pauline Dürr, Phyllis Lensker, Katja Gessner, Lisa Cuba, Rainer Fietkau, Markus F. Neurath, Bernd Wullich, Marianne Pavel, Carola Berking, Matthias W. Beckmann, Andreas Mackensen, Frank Dörje, Martin F. Fromm   +13 more
wiley   +1 more source

Spatial transcriptomics identifies SPARC as a prognostic marker in interstitial lung diseases. [PDF]

J Pathol
Niitsu T, Kataoka T, Fukushima K, Motooka D, Shichino S, Natsume-Kitatani Y, Kitamura H, Niwa T, Baba T, Okuzaki D, Kumanogoh A, Akira S, Okudela K, Ogura T.   +13 more
europepmc   +1 more source

NKX2-1mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “Brain-Lung-Thyroid Syndrome” [PDF]

, 2009
Loïc Guillot, Aurore Carré, Gabor Szinnai, Mireille Castanet, Elodie Tron, Francis Jaubert, Isabelle Broutin, François Counil, Delphine Feldmann, Annick Clement, Michel Polak, Ralph Epaud   +11 more
openalex   +1 more source

Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping Review

Clinical Pharmacology &Therapeutics, EarlyView.
Limited evidence exists synthesizing the risk of acute kidney injury (AKI) associated with the concomitant administration of multiple nephrotoxic drugs, and even less examining the concept of nephrotoxic burden. The objective of this scoping review was to (1) identify definitions of nephrotoxic burden; (2) methods used to quantify (use of calculations)
Wafa Alatawi, Jessica L. Wallace, Dhakrit Rungkitwattanakul, Britney A. Stottlemyer, Tiffany L. Tran, Melanie Manis Reida, Sandra L. Kane‐Gill   +6 more
wiley   +1 more source

Computer-Aided Evaluation of Interstitial Lung Diseases. [PDF]

Diagnostics (Basel)
Colombi D, Marvisi M, Ramponi S, Balzarini L, Mancini C, Milanese G, Silva M, Sverzellati N, Uccelli M, Ferrozzi F.   +9 more
europepmc   +1 more source

Diagnostic and prognostic implications of family history of fibrotic interstitial lung diseases

Shull, Jessica Germaine, Duminy-Luppi, Diego, Alcaide Aldeano, Alex, Planas Cerezales, Lurdes, Bermudo, Guadalupe, Vicens-Zygmunt, Vanesa, Luburich Hernaiz, Patricio, Del Río Carrero, Belén, Llatjós, Roger, Pijuan, Lara, Escobar Campuzano, Ignacio, Rivas Doyague, Francisco, Montes Worboys, Ana, Gutiérrez Rodríguez, Yasmina, Rodríguez-Plaza, David, Padró i Miquel, Ariadna, Esteve García, Anna, Fernández-Varas, Beatriz, Flores, Carlos, Fuentes Prado, Mireya, Dorca i Sargatal, Jordi, Santos Pérez, Salud, Perona, Rosario, Günther, Andreas, Molina-Molina, María   +24 more
openalex   +1 more source

Holistic classification of CT attenuation patterns for interstitial lung diseases via deep convolutional neural networks

, 2016
Mingchen Gao, Ulaş Bağcı, Le Lü, Aaron Wu, Mario Buty, Hoo-Chang Shin, Holger R. Roth, Georgios Z. Papadakis, Adrien Depeursinge, Ronald M. Summers, Ziyue Xu, Daniel J. Mollura   +11 more
openalex   +2 more sources

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma

Clinical Pharmacology &Therapeutics, EarlyView.
Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg, Maaike M. Hofman, Fatima Ashad, Alaa Daloul, Stefani Oosterveld, Edwin A. Basak, Esther Oomen‐de Hoop, Astrid A. M. van der Veldt, Arjen Joosse, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen   +10 more
wiley   +1 more source

Utilisation of cardiopulmonary exercise testing for tailored pulmonary rehabilitation in people with interstitial lung diseases: A systematic review. [PDF]

Clin Rehabil
Bowhay B, Williams CA, Goodrum S, Lacy-Kerr T, Gibbons MA, Scotton CJ, Tomlinson OW.   +6 more
europepmc   +1 more source